Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2015 (2015), Article ID 367837, 5 pages
http://dx.doi.org/10.1155/2015/367837
Research Article

Molecular Backgrounds of ERAP1 Downregulation in Cervical Carcinoma

Department of Pathology, Leiden University Medical Center, L1-Q, 2333 ZA Leiden, Netherlands

Received 16 March 2015; Accepted 28 May 2015

Academic Editor: Motohiro Kojima

Copyright © 2015 Akash M. Mehta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. L. Stern, “Immunity to human papillomavirus-associated cervical neoplasia,” Advances in Cancer Research, vol. 69, pp. 175–211, 1996. View at Google Scholar · View at Scopus
  2. M.-T. Heemels and H. Ploegh, “Generation, translocation, and presentation of MHC class I-restricted peptides,” Annual Review of Biochemistry, vol. 64, pp. 463–491, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Mehta, E. S. Jordanova, G. G. Kenter, S. Ferrone, and G.-J. Fleuren, “Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma,” Cancer Immunology, Immunotherapy, vol. 57, no. 2, pp. 197–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. I. A. York, S.-C. Chang, T. Saric et al., “The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues,” Nature Immunology, vol. 3, no. 12, pp. 1177–1184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. I. A. York, M. A. Brehm, S. Zendzian, C. F. Towne, and K. L. Rock, “Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9202–9207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. G. E. Hammer, F. Gonzalez, M. Champsaur, D. Cado, and N. Shastri, “The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules,” Nature Immunology, vol. 7, no. 1, pp. 103–112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Yan, V. V. Parekh, Y. Mendez-Fernandez et al., “In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules,” The Journal of Experimental Medicine, vol. 203, no. 3, pp. 647–659, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Mehta, E. S. Jordanova, T. van Wezel et al., “Genetic variation of antigen processing machinery components and association with cervical carcinoma,” Genes Chromosomes and Cancer, vol. 46, no. 6, pp. 577–586, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Mehta, E. S. Jordanova, W. E. Corver et al., “Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma,” Genes, Chromosomes and Cancer, vol. 48, no. 5, pp. 410–418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. M. Mehta, V. M. Spaans, N. B. Mahendra et al., “Differences in genetic variation in antigen-processing machinery components and association with cervical carcinoma risk in two Indonesian populations,” Immunogenetics, vol. 67, no. 5-6, pp. 267–275, 2015. View at Publisher · View at Google Scholar
  11. E. Stratikos, A. Stamogiannos, E. Zervoudi, and D. Fruci, “A role for naturally occurring alleles of endoplasmic reticulum aminopeptidases in tumor immunity and cancer pre-disposition,” Frontiers in Oncology, vol. 4, article 363, 2014. View at Publisher · View at Google Scholar
  12. B. Seliger, U. Ritz, and S. Ferrone, “Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation,” International Journal of Cancer, vol. 118, no. 1, pp. 129–138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. W. E. Corver, N. T. ter Haar, E. J. Dreef et al., “High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues,” Journal of Pathology, vol. 206, no. 2, pp. 233–241, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. E. C. A. Abeln, W. E. Corver, N. J. Kuipers-Dijkshoorn, G.-J. Fleuren, and C. J. Cornelisse, “Molecular genetic analysis of ovarian tumour cells: improved detection of loss of heterozygosity,” British Journal of Cancer, vol. 70, no. 2, pp. 255–262, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. R. van Eijk, M. van Puijenbroek, A. R. Chhatta et al., “Sensitive and specific KRAS somatic mutation analysis on whole-genome amplified DNA from archival tissues,” Journal of Molecular Diagnostics, vol. 12, no. 1, pp. 27–34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. de Boer, E. S. Jordanova, G. G. Kenter et al., “High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients,” Clinical Cancer Research, vol. 13, no. 1, pp. 132–138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. L. Andersen, J. L. Jensen, and T. F. Ørntoft, “Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets,” Cancer Research, vol. 64, no. 15, pp. 5245–5250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. C. J. Haven, M. van Puijenbroek, M. Karperien, G.-J. Fleuren, and H. Morreau, “Differential expression of the calcium sensing receptor and combined loss of chromosomes Iq and IIq in parathyroid carcinoma,” The Journal of Pathology, vol. 202, no. 1, pp. 86–94, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Devilee, A.-M. Cleton-Jansen, and C. J. Cornelisse, “Ever since Knudson,” Trends in Genetics, vol. 17, no. 10, pp. 569–573, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Kamphausen, C. Kellert, T. Abbas et al., “Distinct molecular mechanisms leading to deficient expression of ER-resident aminopeptidases in melanoma,” Cancer Immunology, Immunotherapy, vol. 59, no. 8, pp. 1273–1284, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Grommé and J. Neefjes, “Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways,” Molecular Immunology, vol. 39, no. 3-4, pp. 181–202, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Van Kaer, “Major histocompatibility complex class I-restricted antigen processing and presentation,” Tissue Antigens, vol. 60, no. 1, pp. 1–9, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Hasim, M. Abudula, R. Aimiduo et al., “Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women,” PLoS ONE, vol. 7, no. 9, Article ID e44952, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Ogino, K. Nosho, N. Irahara et al., “Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers,” Journal of Clinical Oncology, vol. 27, no. 27, pp. 4591–4598, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. P. T. Campbell, E. T. Jacobs, C. M. Ulrich et al., “Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status,” Journal of the National Cancer Institute, vol. 102, no. 6, pp. 391–400, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Ogino, A. T. Chan, C. S. Fuchs, and E. Giovannucci, “Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field,” Gut, vol. 60, no. 3, pp. 397–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Song, R. Nishihara, M. Wang et al., “Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status,” Gut, 2015. View at Publisher · View at Google Scholar
  28. K. Inamura, M. Yamauchi, R. Nishihara et al., “Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis,” Journal of the National Cancer Institute, vol. 106, no. 9, Article ID dju195, 2014. View at Publisher · View at Google Scholar
  29. K. Inamura, M. Yamauchi, R. Nishihara et al., “Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma,” Annals of Surgical Oncology, vol. 22, no. 4, pp. 1226–1235, 2015. View at Publisher · View at Google Scholar
  30. S. Ogino, P. Lochhead, A. T. Chan et al., “Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease,” Modern Pathology, vol. 26, no. 4, pp. 465–484, 2013. View at Publisher · View at Google Scholar · View at Scopus